Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children | MicrobiomeTrials← Back to trialsNCT07725263
Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-02-01Est. Completion: 2027-02-28
Enrollment target: 30 participants Locations- Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, Hainan, China
Other microbiome trials you might be interested in
Sickle Cell Disease
This is a follow-up trial to NYMC 526 (NCT01461837) to assess the safety, efficacy and toxicity of administering Defibro…
Los Angeles, United StatesEst. completion Dec 2026
Transfusion-dependent Beta-Thalassemia
This is a prospective, dual-centre, single dose, Phase IIb, single arm, open label study. The proposed clinical trial in…
Rome, ItalyEst. completion Oct 2028